2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
- Font Lavagna, Juan PabloEmployéCHUL+1 418-525-4444, poste 48110juan-pablo.font-lavagna@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Gilbert, ÉmilieStagiaireCHUL+1 418-525-4444, poste 48110emilie.gilbert@crchudequebec.ulaval.ca
2705, boulevard Laurier
R0-709
Québec, QC
Canada G1V 4G2 - Gilbert, ÉmilieEmployéCHUL+1 418-525-4444, poste 48110emilie.gilbert@crchudequebec.ulaval.ca
2705, boulevard Laurier
R0-709
Québec, QC
Canada G1V 4G2 - Gilbert, MéganEmployémegan.gilbert@crchudequebec.ulaval.ca
- Obeyi, GerlinsEmployéCHUL+1 418-525-4444, poste 48110gerlins.obeyi@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2 - Ovyn, ManonStagiaireCHUL+1 418-525-4444manon.ovyn@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Pageau, KimEmployékim.pageau@crchudequebec.ulaval.ca
- Rabezanahary, HenintsoaEmployéCHUL+1 418-525-4444, poste 48110+1 418-654-2715Henintsoa.Rabezanaha@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, Québec
Canada G1V 4G2 - Scarrone, MartinaEmployéCHULmartina.scarrone@crchudequebec.ulaval.ca
2705, boulevard Laurier
Québec, QC
Canada G1V 4G2 - Wantchecon, Croix AudeÉtudiant 2e cycleCHUL+1 418-525-4444, poste 48110aude.wantchecon-croix@crchudequebec.ulaval.ca
2705, boulevard Laurier
R-0709
Québec, QC
Canada G1V 4G2
Detection and genome characterisation of SARS-CoV-2 P.6 lineage in dogs and cats living with Uruguayan COVID-19 patients
Article de revueMem Inst Oswaldo Cruz, 117 , 2023.
Symptomatology during previous SARS-CoV-2 infection and serostatus before vaccination influence the immunogenicity of BNT162b2 COVID-19 mRNA vaccine
Article de revueFront Immunol, 13 , 2022.
Epigallocatechin Gallate and Isoquercetin Synergize With Remdesivir to Reduce SARS-CoV-2 Replication In Vitro
Article de revueFront Virol, 2 , 2022.
SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
Article de revueEmerg Infect Dis, 28 (11), 2022.
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021
Article de revueCommun Dis Intell (2018), 46 , 2022.
Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic
Article de revueSci Rep, 12 (1), 2022.
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infection
Article de revueNanomedicine, 44 , 2022.
World Society for Virology first international conference: Tackling global virus epidemics
Article de revueVirology, 566 , 2022.
Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors
Article de revueAntiviral Res, 200 , 2022.
Preclinical and clinical developments for combination treatment of influenza
Article de revuePLoS Pathog, 18 (5), 2022.
Projets actifs
- Fonds de démarrage, Mariana Baz. La grippe à l'interface entre l'homme et l'animal: émergence et contrôle, du 2020-04-13 au 2023-04-12
- Immunité cellulaire et séroprévalence des anticorps contre SARS-COV-2: Caractérisation de trois populations de travailleurs de l'alimentation, du 2020-11-01 au 2023-03-31
- Preclinical proof of concept studies of a new generation of TLR7/8 agonist used in prevention against respiratory viruses and in immunotherapy against lung cancer, du 2023-03-01 au 2024-02-29
Projets terminés récemment
- Effects of high polyphenol doses on the replication of COVID-19 in vitro, du 2020-05-01 au 2021-04-30
- Effects of high polyphenol doses on the replication of COVID-19 in vitro, du 2020-06-01 au 2021-11-30
- Innovative therapeutic approaches for the 2019-novel coronavirus, du 2021-03-01 au 2022-02-28
- Prevention of the immunopathology induced by SARS-CoV-2, du 2021-06-01 au 2022-05-31
- Repositionnement du fumarate de diméthyle pour traiter la COVID-19: une molécule à double action au potentiel antiviral et anti-inflammatoire, du 2020-05-11 au 2021-04-30
- Sex as a Biological Variable Supplement - Innovative therapeutic approaches for the 2019-novel coronavirus, du 2020-05-01 au 2021-03-31
- Understanding the pathogenesis of COVID-19, du 2020-03-01 au 2023-02-28